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Effective Control of Chronic c-Herpesvirus
Infection by Unconventional
MHC Class Ia–Independent CD8 T Cells
Douglas C. Braaten1,2[a, James Scott McClellan1,2[a, Ilhem Messaoudi3[a, Scott A. Tibbetts1,2, Kelly B. McClellan1,2,
Janko Nikolich-Zugich3[b, Herbert W. Virgin IV1,2[b*
1 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America, 2 Department of Molecular
Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America, 3 Department of Microbiology and Immunology, Oregon Health and
Science University, Beaverton, Oregon, United States of America

Control of virus infection is mediated in part by major histocompatibility complex (MHC) Class Ia presentation of viral
peptides to conventional CD8 T cells. Although important, the absolute requirement for MHC Class Ia–dependent CD8
T cells for control of chronic virus infection has not been formally demonstrated. We show here that mice lacking MHC
Class Ia molecules (Kb/xDb/ mice) effectively control chronic c-herpesvirus 68 (cHV68) infection via a robust
expansion of b2-microglobulin (b2-m)-dependent, but CD1d-independent, unconventional CD8 T cells. These
unconventional CD8 T cells expressed: (1) CD8ab and CD3, (2) cell surface molecules associated with conventional
effector/memory CD8 T cells, (3) TCRab with a significant Vb4, Vb3, and Vb10 bias, and (4) the key effector cytokine
interferon-c (IFNc). Unconventional CD8 T cells utilized a diverse TCR repertoire, and CDR3 analysis suggests that some
of that repertoire may be utilized even in the presence of conventional CD8 T cells. This is the first demonstration to
our knowledge that b2-m–dependent, but Class Ia–independent, unconventional CD8 T cells can efficiently control
chronic virus infection, implicating a role for b2-m–dependent non-classical MHC molecules in control of chronic viral
infection. We speculate that similar unconventional CD8 T cells may be able to control of other chronic viral infections,
especially when viruses evade immunity by inhibiting generation of Class Ia–restricted T cells.
Citation: Braaten DC, McClellan JS, Messaoudi I, Tibbetts SA, McClellan KB, et al. (2006) Effective control of chronic c-herpesvirus infection by unconventional MHC Class Ia–
independent CD8 T cells. PLoS Pathog 2(5): e37. DOI: 10.1371/journal.ppat.0020037

splenocytes and peritoneal cells has been extensively characterized in wild-type mice, and two forms of cHV68 latency
have been observed [23,25,30,31]. An early form of latency
occurs by 16 d after infection that is characterized by a high
efﬁciency of reactivation from latency (i.e., frequency of
reactivation per number of latently infected cells) in an ex
vivo assay, with the majority of genome-bearing cells
reactivating [23,30]. A second, long-term form of latency
occurs 28–42 d after infection and is characterized by a lower
efﬁciency of reactivation ex vivo, with approximately 10% of
genome-bearing cells reactivating [23,25,30]. This long-term
form of latency reﬂects a stable relationship between the
virus and the host that is independent of both dose and route

Introduction
A deﬁning characteristic of herpesviruses is their ability to
persist for the life of the infected host by establishing latent
infection after acute infection is cleared. Herpesviruses can
reactivate from latency, generating new infectious virus that
can either re-initiate lytic replication (a process termed
herein ‘‘persistent replication,’’ to distinguish it from
replication during acute infection) or spread to a new host.
Many c-herpesviruses, including the human pathogens
Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated
herpesvirus (KSHV), and the murine pathogen c-herpesvirus 68
(cHV68), establish life-long latent infections within hematopoietic cells [1–6]. Consequently, chronic c-herpesvirus
infections are frequently associated with the development
of B cell malignancies, especially in immunocompromised
individuals [7–12]. c-Herpesvirus-associated diseases are
particularly common in immunocompromised hosts, a fact
indicating that the immune system normally controls chronic
c-herpesvirus infection and thereby prevents disease
[10,11,13–16].
Immune control of chronic cHV68 infection has been
studied extensively as a model for deﬁning viral and host
mechanisms that are responsible for maintaining latency as a
stable equilibrium between virus and host [15–28]. After
either intranasal or intraperitoneal infection [1,23], cells that
harbor latent cHV68 can be found in hematopoietic organs
such as the bone marrow and spleen, and in body cavities
such as the peritoneum [1–5,29]. Latent cHV68 infection of
PLoS Pathogens | www.plospathogens.org
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Synopsis

both lytic and latent cHV68 antigens are presented by Class
Ia on infected cells during chronic infection. These data are
supported by published studies demonstrating that either
CD8 deﬁciency or b2-microglobulin (b2-m) deﬁciency is
associated with increased latency and persistent replication
[25,40–42], and by studies showing that antibody-mediated
depletion of CD8 T cells from wild-type mice results in
increased latent infection [20,43].
That classical CD8 T cells are involved in control of cHV68
infection is consistent with a critical role for Class Ia
molecules in presenting cHV68-encoded antigens; however,
the requirement for Class Ia molecules for control of
infection has not been formally tested. This is of interest
because some published studies suggest that unconventional
T cells are stimulated during cHV68 infection. For example,
T cell hybridomas isolated from cHV68-infected mice can
respond to cHV68-infected cells in the absence of TAP1 or
b2-m [42,44]. However, the use of b2-m/ mice and cells as
models for Class Ia deﬁciency is complicated by the fact that
b2-m is also an important accessory molecule for the cell
surface expression of multiple non-classical major histocompatibility complex (MHC) Class Ib molecules, including CD1d,
M3, FcRn, Qa-1, and HFE (reviewed in [45,46]). It has also
been reported that b2-m/ mice are not completely Class Ia
deﬁcient [47–49].
To circumvent these limitations, we evaluated cHV68
infection in Class Ia–deﬁcient (Class Ia) mice (Kb/xDb/)
[50,51] and in mice deﬁcient in both Class Ia and b2-m
molecules (Kb/xDb/xb2-m/) [52]; Kb/xDb/xb2-m/ mice
lack expression of both Class Ia and b2-m–dependent Class Ib
molecules. Because the non-classical Class Ib molecule CD1d
has been implicated in control of herpesvirus infection ([53],
reviewed in [54]), we also analyzed mice deﬁcient in both
Class Ia and CD1d (Kb/xDb/xCD1d/). We found that mice
lacking Class Ia molecules mount a substantial effector CD8 T
cell response that requires b2-m but not CD1d. These
unconventional effector CD8 T cells effectively controlled
latent cHV68 infection. These data suggest that unconventional T cells could play an important role in control of other
chronic viral infections, with important implications for the
study of antigens recognized by CD8 T cells during chronic
infection and, especially, for viruses that evade immunity by
inhibiting MHC Class Ia expression.

In this paper the authors identify a b2-microglobulin–dependent but
major histocompatibility complex (MHC) Class Ia– and CD1independent class of CD8 T cells that effectively control chronic cherpesvirus infection in mice. The important point that should be of
general interest to the readers of PLoS Pathogens is that an effective
CD8 T cell response develops during chronic infection of mice
lacking MHC Class Ia molecules. Enormous efforts have gone into
characterizing the role of conventional CD8 T cells that recognize
viral peptides together with MHC Class Ia molecules during chronic
viral infection, and many vaccine approaches focus solely on this
response. This paper shows that additional types of CD8 T cells can
operate during chronic infection, and that indeed, conventional
MHC Class Ia–restricted T cells may be dispensable for control of
chronic herpesvirus infection. The authors believe this is a
fundamentally important point because it raises the question of
whether unconventional CD8 T cells are important for control of
other chronic viral infections such as infection with HIV, Hepatitis C
virus, Hepatitis B virus, or human herpesviruses.

of virus infection [23], but which can be perturbed by
immunodeﬁciency [15,25,30,31]. During this equilibrium
phase of latency, sensitive assays can detect a very small
amount of infectious virus in some mice, consistent with
reactivation from latency and persistent replication [29].
The immune system normally controls latency and chronic
infection at several levels, including immune-mediated
decreases in the number of latently infected cells
[17,19,20,25] and regulation of the efﬁciency of reactivation
from latency [25]. Different components of the immune
system have speciﬁc roles in regulating cHV68 latency at
different sites; for example, the absence of interferon-c (IFNc)
increases the efﬁciency of reactivation of latently infected
peritoneal but not spleen cells [25,31]. In addition to
regulating latency, the immune system normally prevents
most persistent lytic replication, which ﬂares in immunocompromised mice, especially those lacking CD8 or IFNc
[15,16,25,29,32–34]. In addition to its role in limiting
persistent replication, IFNc (as well as IFNab) regulates latent
cHV68 gene expression in vivo, and IFNc can directly inhibit
the reactivation of cHV68 from latency [32,33]. Persistent
replication requires genes such as the v-bcl2 and v-cyclin that
are not required for replication during acute infection, which
indicates that persistent replication occurs by a distinct
mechanism from that required for acute replication [31,35].
Persistent replication is likely critical for the maintenance of a
constant pool of latently infected cells [27,34,36] by infection
and establishment of latency in uninfected target cells.
A large body of evidence indicates that CD8 T cells are
important for control of acute, latent, and persistent cHV68
infection. CD8 T cell responses directed against Class Ia–
presented peptides derived from lytic cycle proteins are
detectable as early as 10 d after infection [21,37]. These CD8 T
cells actively cycle for many months after infection [22,37,38],
which is consistent with a role for CD8 T cells in the control
of persistent replication [25]. TCR transgenic CD8 T cells that
recognize the SIINFEKL peptide of ovalbumin can control
infection of a recombinant cHV68 virus that expresses
ovalbumin [19]. Furthermore, CD8 T cells that recognize
the latency-associated cHV68 antigen M2 control the early
form of cHV68 latency [28,39]. These data demonstrate that
PLoS Pathogens | www.plospathogens.org

Results
Class Ia–Deficient Mice Effectively Control Acute cHV68
Infection
To begin to evaluate the role of Class Ia molecules during
cHV68 infection, acute virus replication was compared in
strains of mice 9 d after intraperitoneal injection of 106
plaque forming units (PFU) of wild-type cHV68. Spleens from
B6, CD8/, b2-m/, Kb/xDb/, Kb/xDb/xb2-m/, and Kb/
xDb/xCD1d/ mice were harvested, and the titer of virus
present was determined (Figure 1A, Table 1). There were no
signiﬁcant differences in titers in the spleens from wild-type,
Kb/xDb/, and Kb/xDb/xCD1d/ mice, whereas mice lacking either CD8 or b2-m demonstrated splenic titers that were
8.7-fold (p ¼ 0.03) and 5.1-fold (p ¼ 0.04) higher, respectively,
as compared to wild-type mice. We noted that Kb/xDb/xb2m/ mice failed to control infection compared to either Kb/
xDb/ or wild-type mice. Furthermore, lack of CD8 resulted in
0395

May 2006 | Volume 2 | Issue 5 | e37

Virus Control by Unconventional CD8 T Cells

Figure 1. Class Ia–Deficient Mice Effectively Control cHV68 Infection in a b2-m– and CD8 T Cell–Dependent Manner
(A) Log viral titers in spleen of B6, CD8a/, b2-m/, Kb/xDb/, Kb/xDb/xCD1d/, and Kb/xDb/xb2-m/ mice 9 d after intraperitoneal infection
with 106 PFU of virus. Data were pooled from two experiments consisting of two to three mice each. An asterisk (*) indicates a significant increase in
viral titer relative to B6 (p , 0.05).
(B) Frequency of cells reactivating from latency ex vivo (left), frequency of cells bearing viral genome (middle), and persistent replication (right, open
symbols) at day 42 post-infection in peritoneal cells from B6, b2-m/, Kb/xDb/, Kb/xDb/xCD1d/, and Kb/xDb/xb2-m/ mice. On the y-axis is
the percentage of wells positive for viral cytopathic effect (left and right) or viral genome (middle). The horizontal line within the graph indicates the
63.2% Poisson distribution line used to calculate the frequency of cells reactivating virus. For each group, cells were pooled from three to five mice. Data
are the mean of three to four independent experiments 6 SEM.
(C) Frequency of latent infection in splenocytes from B6, b2-m/, Kb/xDb/, Kb/xDb/xCD1d/, and Kb/xDb/xb2-m/ mice. For each group, cells
were pooled from three to five mice. Data are the mean of three to four independent experiments 6 SEM.
(D) cHV68 latency at day 16 post-infection in peritoneal cells from Kb/xDb/xCD1d/ mice either untreated, treated with a control antibody (Ab), or
depleted of CD8 T cells beginning 1 d prior to infection. Left: ex vivo reactivation of peritoneal cells from control-treated and CD8-depleted groups.

PLoS Pathogens | www.plospathogens.org
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Middle: frequency of peritoneal cells that contain viral genome in control-treated and CD8-depleted groups. Right: persistent replication in peritoneal
cells from control-treated and CD8-depleted groups.
(E) cHV68 latency at day 16 post-infection in splenocytes from Kb/xDb/xCD1d/ mice either untreated, treated with a control antibody, or depleted
of CD8 T cells beginning 1 d prior to infection. For each group in D and E, cells were pooled from three to five mice. Data are the mean of three
independent experiments 6 SEM.
DOI: 10.1371/journal.ppat.0020037.g001

CD8aaþ CD8 T cells [55,57,59,60]. Kb/xDb/xCD1d/ mice
were either mock treated or treated with a CD8bþ cell–
depleting antibody during infection. The extent of CD8 T cell
depletion was assessed by ﬂuorescence-activated cell sorter
(FACS) assay and was found to be equal to or greater than
94% effective in these experiments (Figure S2).
Depletion of CD8bþ T cells resulted in loss of control of
chronic infection in the Class Ia–deﬁcient mice (Figure 1D
and 1E, Tables 4 and 5). Loss of control was especially evident
in peritoneal cells in which the majority of latently infected
cells are macrophages [1], because the frequency of cells
reactivating virus, the frequency of cells positive for viral
genome, and the amount of persistent replication were all
increased (Figure 1D). These data showed that CD8 T cells
were required to control chronic cHV68 infection in mice
lacking Class Ia molecules, consistent with the hypothesis that
these CD8 T cells were stimulated by a Class Ia–independent
mechanism.

decreased control of cHV68 replication even though lack of
Class Ia molecules did not. Although there are several
potential explanations for these ﬁndings, these data could
be explained if a b2-m–dependent, but Class Ia–independent,
population of CD8 T cells was important for the control of
infection observed in the Kb/xDb/ mice.

Class Ia–Deficient Mice Effectively Control Chronic cHV68
Infection
We next evaluated the role of Class Ia molecules in control
of chronic cHV68 infection in peritoneal cells and splenocytes from B6, Kb/xDb/, and Kb/xDb/xCD1d/ mice
(Figure 1B and 1C, Tables 2 and 3). As read-outs for chronic
infection we quantiﬁed the frequency of latently infected
cells bearing viral genome, the frequency of latently infected
cells that reactivated from latency when explanted onto
murine embryonic ﬁbroblast (MEF) monolayers, and persistent virus replication [23,25]. Mice lacking Class Ia or both
Class Ia and CD1d were able to control chronic cHV68
infection in both the peritoneum and spleen as well as wildtype mice, as measured by either the frequency of cells that
reactivate from latency or the frequency of latently infected
cells carrying viral genome (Figure 1B and 1C). Thus, as
observed for acute infection, mice lacking Class Ia or both
Class Ia and CD1d molecules exhibited a signiﬁcant capacity
to control chronic cHV68 infection.

Control of Chronic cHV68 Infection in Class Ia–Deficient
Mice Is Associated with Stimulation and Expansion of
Unconventional CD8 T Cells
To more directly assess our hypothesis that CD8 T cells
were present in the Class Ia–deﬁcient mice, splenocytes from
mock infected and infected B6, CD8/, b2-m/, Kb/xDb/,
Kb/xDb/xCD1d/, and Kb/xDb/xb2-m/ mice were characterized for the presence of CD4 and CD8 T cells and for the
absolute number and percentage of CD8 T cells. In agreement with previously reported observations, uninfected mice
lacking Class Ia molecules (Kb/xDb/ and Kb/xDb/xCD1d/
mice) had a signiﬁcantly lower percentage of CD8 T cells
compared to B6 mice (Figure 2A and 2B). This phenotype was
even more pronounced in mice lacking both MHC Class Ia
and b2-m, which was expected because these mice lack
expression of all Class Ia and b2-m–dependent Class Ib
molecules. In infected B6, Kb/xDb/, and Kb/xDb/xCD1d/
mice, however, the percentages and absolute numbers of both
CD4 and CD8 T cells were similar (Figure 2A and 2B),
indicating that viral infection stimulated a massive expansion
of CD8 T cells in mice lacking the Class Ia and CD1d
molecules. To conﬁrm that the CD8 T cells observed in the
spleens of infected Kb/xDb/ mice were T cells, CD8þ
splenocytes from Kb/xDb/ mice were further characterized
by ﬂow cytometry and shown to express TCRb, CD3, and
CD8b (Figure 2C). These data demonstrated that the
unconventional CD8þ cells that expand in Kb/xDb/ mice
after cHV68 infection were indeed CD8 T cells.
We compared the expansion of CD8 T cells in Class Ia–
deﬁcient mice to that observed in mice lacking both Class Ia
and b2-m (Figure 2A and 2B). There was an increase in CD8 T
cells in mice lacking both Class Ia and b2-m, and a signiﬁcant
part of the CD8 T cell expansion in Class Ia–deﬁcient mice
was b2-m dependent. We speculate that the T cells that
develop in the absence of both b2-m and Class I may be
related to cells previously shown to respond to cHV68
infection in the absence of b2-m [42,44].

Control of Chronic cHV68 Infection in Class Ia–Deficient
Mice Is Dependent on b2-m and CD8 T Cells
Having shown that MHC Class Ia molecules are not
required for control of either acute or chronic cHV68
infection, we next determined if control of chronic cHV68
infection in the absence of Class Ia required b2-m or CD8 T
cells. B6, b2-m/, Kb/xDb/, and Kb/xDb/xb2-m/ mice were
evaluated at 42 d post-infection. For both peritoneal cells and
splenocytes, all measures of latent infection in b2-m/ and
Kb/xDb/xb2-m/ mice indicated signiﬁcant loss of control
compared to wild-type and Kb/xDb/ mice (Figure 1B and
1C, Tables 2 and 3). Together, these data strongly indicated
that control of cHV68 latency and persistent replication is b2m dependent in either the presence or absence of Class Ia
molecules.
Since CD8 T cells were important for control of chronic
cHV68 infection ([25], and Figure S1), even when Class Ia
molecules were not (Figure 1), these data were consistent with
the hypothesis that a Class Ia–independent, but b2-m–
dependent, CD8 T cell response was able to control cHV68
infection. We therefore determined if CD8 T cells were
important for control of chronic cHV68 infection in the
absence of Class Ia molecules. Since dendritic cells are
latently infected with cHV68 [4] and can express CD8a [55–
57], we wished to deplete CD8abþ T cells without altering
dendritic cells. Furthermore, we wished to avoid depleting
unconventional CD8aaþ T cells that develop in mice lacking
Class Ia [58]. We therefore selected a depleting antibody
speciﬁc for CD8b that is not expressed on dendritic cells or
PLoS Pathogens | www.plospathogens.org
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Table 1. Viral Titer in Spleen 9 Days after Infection
Genotype

Viral Titer per Spleen, Day 9 Post-Infection

p-Value

Titer (Fold Increase versus B6)

B6
CD8a/
b2-m/
Kb/xDb/
Kb/xDb/xb2-m/
Kb/xDb/xCD1/

630
5,400
3,160
830
5,400
890

—
0.03
0.04
NS
0.01
NS

—
8.6-fold
5.1-fold
No change
8.6-fold
No change

Table represents the tabulation of the data presented in Figure 1A.
NS, not significant.
DOI: 10.1371/journal.ppat.0020037.t001

Table 2. Peritoneal Exudate Cells, Day 42 Post-Infection
Genotype

Frequency of
PECs Reactivating

p-Value

Reactivation (Fold
Increase versus B6)

Frequency of
Genome-Positive PECs

p-Value

Genome Frequency
(Fold Increase versus B6)

B6
CD8a/
b2-m/
Kb/xDb/
Kb/xDb/xb2-m/
Kb/xDb/xCD1/

1/20,000
1/1,100
1/840
1/27,000
1/80
1/21,000

—
,0.001
,0.001
NS
,0.001
NS

—
18-fold
23-fold
No change
250-fold
No change

1/1,500
1/700
1/250
1/1,700
1/40
1/3,000

—
NS
0.04
NS
0.03
NS

—
No change
6-fold
No change
36-fold
No change

Table represents the tabulation of the data presented in Figure 1B.
NS, not significant; PEC, peritoneal exudate cell.
DOI: 10.1371/journal.ppat.0020037.t002

Table 3. Splenocytes, Day 42 Post-Infection
Genotype

Frequency of
Splenocytes
Reactivating

p-Value

Reactivation
(Fold Increase
versus B6)

Frequency of
Genome-Positive
Splenocytes

p-Value

Genome Frequency
(Fold Increase
versus B6)

B6
CD8a/
b2-m/
Kb/xDb/
Kb/xDb/xb2-m/
Kb/xDb/xCD1/

,1/100,000
1/60,000
1/15,000
1/100,000
1/12,000
,1/100,000

—
0.04
,0.01
NS
,0.01
NS

—
At least 1.6-fold
At least 6-fold
No change
At least 8-fold
No change

1/1,600
1/230
1/90
1/300
1/40
1/530

—
NS
0.03
NS
,0.01
NS

—
No change
18-fold
No change
37-fold
No change

Table represents the tabulation of the data presented in Figure 1C.
DOI: 10.1371/journal.ppat.0020037.t003

Unconventional CD8 T Cells Induced by cHV68 Infection
in Class Ia–Deficient Mice Demonstrate an Activated
Phenotype

antibodies speciﬁc for the cdT cell receptor; all of which were
negative on both mock-infected and infected unconventional
CD8 T cells. Finally, the cells were evaluated for expression of
known CD8 T cell–associated NK cell markers characteristic
of activated cytotoxic CD8 T cells [63]. The unconventional
CD8 T cells were highly positive for NKG2A and expressed
elevated amounts of NKG2D. Together, these results were
consistent with the unconventional CD8 T cells being
effector/memory cells and, therefore, with the cells being
anti-viral T cells.

We further evaluated the CD8 T cells that expand during
infection of Class Ia–deﬁcient mice by determining whether
they express cell surface markers observed on conventional
Class Ia–dependent effector/memory CD8 T cells. Using ﬂow
cytometry, we compared expression of cell surface markers
between mock-infected Class Ia–deﬁcient mice and mice that
had been infected for 42 d (Figure 3). The results were
consistent with the cells being effector/memory cells (CD43þ,
CD69þ/, CD62L-low, CD122þ/ [IL2Rb chain], CD127-low
[IL7Ra chain]) [61–63]. We also evaluated the cells for the
pan–natural killer (NK) cell surface marker DX5 (CD49b) and
PLoS Pathogens | www.plospathogens.org

Unconventional CD8 T Cells Are Vb4-Biased after cHV68
Infection
In wild-type, b2-m/, and TAP1/ mice, the CD8 T cell
response to cHV68 is Vb4 biased [26,42]. We therefore used
0398
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Table 4. Peritoneal Cells, Day 16 Post-Infection.
Genotype

Frequency
of PECs
Reactivating

p-Value

Reactivation
(Fold Increase
versus Control
Ab-Treated Group)

Frequency of
Genome-Positive
PECs

p-Value

Genome Frequency
(Fold Increase
versus Control
Ab–Treated Group)

Kb/xDb/xCD1/ control Ab
Kb/xDb/xCD1/ untreated
Kb/xDb/xCD1/ anti-CD8b

1/590
1/430
1/50

—
NS
,0.01

—
No change
11-fold

1/300
Not performed
1/40

—
—
,0.01

—
—
At least 7-fold

Table represents the tabulation of data as presented in Figure 1D.
Ab, antibody; NS, not significant; PEC, peritoneal exudate cell.
DOI: 10.1371/journal.ppat.0020037.t004

Table 5. Splenocytes, Day 16 Post-Infection
Genotype

Frequency of
Splenocytes
Reactivating

p-Value

Reactivation
(Fold Increase
versus Control
Ab-Treated Group)

Frequency of
Genome-Positive
Splenocytes

p-Value

Genome Frequency
(Fold Increase
versus Control
Ab-Treated Group)

Kb/xDb/xCD1/ control Ab
Kb/xDb/xCD1/ untreated
Kb/xDb/xCD1/ anti-CD8b

1/6,400
1/6,300
1/2,400

—
NS
,0.01

—
No change
3-fold

1/60
Not performed
1/50

—
—
NS

—
—
No change

Table represents the tabulation of data presented in Figure 1E.
Ab, antibody; NS, not significant.
DOI: 10.1371/journal.ppat.0020037.t005

T Cell Receptor Diversity in Unconventional CD8 T Cells
that Control Chronic cHV68 Infection

ﬂow cytometry to characterize Vb usage in infected versus
control B6, Kb/xDb/, and Kb/xDb/xb2-m/ mice (Figure
4A and 4B). For CD4 T cells, Vb usage was not signiﬁcantly
skewed by cHV68 infection; for CD8 T cells, Vb usage was
predominantly Vb4 biased after infection. This contrasts with
uninfected Class Ia–deﬁcient mice, which have previously
been shown not to have biased Vb TCR usage compared to
wild-type mice [64]. The percentage of total splenic CD8 T
cells expressing Vb4 increasing from 6% to approximately
40% by 42 d after infection (Figure 4A). In infected Kb/xDb/
mice, the percentage of Vb4 T cells (about 70%) was much
higher than that observed in B6 mice. These results
conﬁrmed that Class Ia molecules are not required for
stimulating the Vb4 T cells [42] and that the majority of CD8
T cells in Class Ia–deﬁcient mice were biased toward Vb4
usage. In infected Kb/xDb/xb2-m/ mice, however, the
percentage of CD8 T cells that express Vb4 was signiﬁcantly
less (p , 0.01) than that seen in Kb/xDb/ mice (Figure 4A),
which was consistent with the stimulation of Vb4 CD8 T cells
in Kb/xDb/ mice being signiﬁcantly but not completely
dependent on b2-m.
In addition to the increase in Vb4 usage, we observed that
both Vb3 and Vb10 usage were maintained in infected as
compared to uninfected Class Ia–deﬁcient mice (Figure 4C).
Given the large increase in total CD8 T cells stimulated by
cHV68 infection, this indicated that both Vb3- and Vb10expressing T cells expanded in infected Class Ia–deﬁcient
mice, although to a lesser extent than Vb4-expressing T cells.
Together these data demonstrated signiﬁcant Vb bias in CD8
T cells that develop during chronic cHV68 infection of Class
Ia–deﬁcient mice.
PLoS Pathogens | www.plospathogens.org

The above bias could be due to a very limited repertoire of
T cells selected on and restricted by Class Ib MHC molecules;
in which case only a few clones could account for the
expansion of Vb4 and other families. To assess clonal
complexity of unconventional CD8 T cells that develop
during cHV68 infection, we compared CDR3 length complexity in CD8 T cells from infected and uninfected mice. CDR3
regions are the most polymorphic parts of the TCR, and their
diversity is representative of T cell diversity within a given
population. CDR3 length analysis determines in a population
of cells the relative abundance of mRNAs encoding TCRs
with speciﬁc CDR3 lengths (usually between 18–39 base pairs
(bp) encoding CDR3 regions of 6–13 amino acids) [65]. In
young, non-immunized mice, this analysis reveals within each
TCR Vb family a pattern of CDR3 length peaks spaced 3 bp
apart in a Gaussian distribution around the most frequent
length (27–30 bp encoding 9–10 amino acids), representative
of a diverse T cell repertoire [65]. Antigenic challenge induces
expansion of a handful of Ag-speciﬁc T cell clones, leading to
relative or absolute dominance of one (monoclonal response)
or a few (oligoclonal response) peaks in the proﬁle [66,67].
During the contraction phase of the T cell response,
expanded T cell clones die by apoptosis, restoring the
Gaussian CDR3 length proﬁle. Therefore, distorted proﬁles,
with a few, or only a single, peak, are strongly suggestive of
restricted TCR utilization, whereas a Gaussian distribution of
CDR3 lengths within proliferating T cells is indicative of
diverse TCR utilization.
CDR3 length analysis revealed that the CD8 T cells from a
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Figure 2. Control of Chronic cHV68 Infection Is Associated with Stimulation of Unconventional CD8 T Cells
Splenocytes were harvested from B6, CD8a/, b2-m/, Kb/xDb/, Kb/xDb/xb2-m/, and Kb/xDb/xCD1d/ mice 42 d after mock infection or
cHV68 infection and analyzed by flow cytometry.
(A) Representative flow cytometric analysis of CD4 and CD8 expression on splenocytes from B6, Kb/xDb/, and Kb/xDb/xb2-m/ mice that were
either mock infected or cHV68 infected for 42 d.
(B) Absolute number of splenocytes expressing CD8a in mice that were mock infected or infected with cHV68 for 42 d. Data are the mean of four to
eight independent experiments using three to five mice per group, 6 SEM.
(C) Representative flow cytometric analysis of TCRb, CD3, CD8b, and CD8a expression on splenocytes from B6, Kb/xDb/ mice that were either mock
infected or cHV68 infected for 42 d.
DOI: 10.1371/journal.ppat.0020037.g002
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Figure 3. CD8 T Cells Induced by cHV68 Infection in Class Ia–Deficient Mice Demonstrate an Activated Phenotype
Splenocytes were harvested from Kb/xDb/ mice 42 d after mock infection or cHV68 infection. CD8aþ splenocytes from these mice were analyzed by
flow cytometry for cell surface expression of markers of effector/memory phenotype and expression of NK and T cell markers. Panels are representative
of the flow cytometric analysis from two independent experiments.
DOI: 10.1371/journal.ppat.0020037.g003

Class Ia–independent anti-cHV68 CD8 T cell response
encompasses substantial diversity, indicating that the development of these cells is not restricted to a limited and highly
specialized subset of T cells.

broad range of Vb families retained CDR3 length diversity in
cHV68-infected wild-type mice (unpublished data and Figure
5), suggesting that numerous T cell clones from a variety of
Vb families respond to chronic cHV68 infection. This
included the dominant Vb4þ population of T cells that
showed signs of polyclonal response (Figure 5). In contrast,
the CDR3 length proﬁles of unconventional CD8 T cells that
developed in infected Kb/xDb/ mice revealed two patterns
(Figure 5, and unpublished data). The dominant Vb4 and
subdominant Vb10 families, comprising more than 80% of
the total CD8 response of Kb/xDb/ mice, displayed diversity
similar to that seen in wild-type mice. This suggests that much
of the response in both wild-type and MHC Class Ia–deﬁcient
mice to cHV68 is diverse. Of note, the subdominant Vb10
response in both the wild-type and Kb/xDb/ mice included
an asymmetric peak to the right of the center (Figure 5,
arrows), suggesting that the response in normal animals may
include Class Ia–independent clones. A second pattern was
seen in the case of Vb3 and Vb20 TCR families, where peaks
suggestive of oligoclonal or monoclonal expansions are seen
in Class Ia–deﬁcient, but not wild-type, animals (Figure 5).
Sequencing analysis is in progress to ascertain that some of
the Class Ia–independent clones are invoked in the response
of wild-type animals. Together, these data indicated that the
PLoS Pathogens | www.plospathogens.org

Unconventional CD8 T Cells Express Effector Molecules in
Infected Class Ia–Deficient Mice
Because unconventional CD8 T cells were capable of
controlling cHV68 infection in Class Ia–deﬁcient mice (Figure
1), we examined their capacity to express effector molecules
known to be important for control of chronic cHV68 infection.
We focused on expression of IFNc, which is of proven
importance for control of latent cHV68 infection, reactivation
of cHV68 from latency, and persistent cHV68 replication
[15,16,25,31–33]. The unconventional CD8 T cells in splenocytes from Kb/xDb/ mice were compared to CD8 T cells in
splenocytes from B6 mice. Detection of the expression of
cytokines by effector CD8 T cells in other viral systems often
requires re-stimulation of cells in vitro. As we do not know the
antigen speciﬁcity of the unconventional CD8 T cells that
develop in cHV68-infected Class Ia–deﬁcient mice, we restimulated cells with phorbol myristate acetate (PMA) and ionomycin
prior to staining for expression of IFNc and tumor necrosis
factor-a (TNFa). Unstimulated cells expressed only low levels of
IFNc and TNFa in these experiments (unpublished data).
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Figure 4. CD8 T Cells from cHV68-Infected Class Ia–Deficient Mice Are
Vb4 Biased
Splenocytes were harvested from B6, b2-m/, Kb/xDb/, Kb/xDb/
xb2-m/, and Kb/xDb/xCD1d/ mice 42 d after mock infection or
cHV68 infection. TCR Vb usage by CD4 and CD8 T cells from these mice
was assessed by flow cytometry.
(A) Percentage of total CD8aþ splenocytes that co-express Vb4. Data are
the mean of four to eight independent experiments using three to five
mice per group, 6 SEM.
(B) Absolute number of CD8aþVb4 and CD8aþVb4þ splenocytes. Data are
the mean of four to eight independent experiments using three to five
mice per group, 6 SEM.
(C) TCR Vb analysis of CD4 and CD8 T cells obtained from the spleens of
Kb/xDb/ mice 42 d after mock-infection or cHV68 infection.
Data are the mean 6 SEM of three independent experiments.
DOI: 10.1371/journal.ppat.0020037.g004

CD8 T cells from mock-infectedB6 mice produced little
TNFa and no IFNc even after stimulation with PMA and
ionomycin. In contrast, approximately 11% of CD8 T cells
from uninfected Kb/xDb/ mice produced both TNFa and
IFNc after PMA and ionomycin stimulation, whereas smaller
populations of cells produced either TNFa or IFNc alone
(Figure 6A). These data demonstrated a functional difference
between unstimulated conventional and unconventional CD8
T cells, and indicate that even in naive Kb/xDb/ mice, the
CD8 T cells were in a partially activated state. These ﬁndings
are consistent with previous data obtained in characterizing
these cells [58,68].
In B6 mice 42 d after infection, PMA and ionomycin
treatment induced a signiﬁcant percentage of CD8 T cells to
express IFNc, TNFa, or both cytokines (Figure 6A). Similarly,
infection of Kb/xDb/ mice resulted in a signiﬁcant increase
in the proportion of PMA and ionomycin–stimulated cells
that expressed IFNc (Figure 6A). Because the majority of CD8
T cells that develop in cHV68-infected Class Ia–deﬁcient
mice express Vb4, we also examined cytokine expression in
Vb4 CD8 T cells (Figure 6B and 6C). In both wild-type and
Class Ia–deﬁcient mice, cHV68 infection induced a signiﬁcant increase in CD8 T cells expressing IFNc (Figure 6B and
6C). It would be of interest to examine these cells for the
expression of IFNab, which also can control cHV68 latency
[33]. These data were consistent with CD8 T cells in both B6
and Kb/xDb/ mice acquiring an activated phenotype after
cHV68 infection, conﬁrming our conclusions from analysis of
cell surface molecule expression on these cells (Figure 3).
Because IFNc is important for control of cHV68 latency and
persistent replication, these data indicated that cHV68induced CD8 T cells that develop in Class Ia–deﬁcient mice
express important anti-viral effector molecules.

Discussion
We present data in this paper demonstrating that unconventional CD8 T cells arise in infected Class Ia–deﬁcient
mice. We show furthermore that these unconventional CD8 T
cells express surface markers and cytokines consistent with
memory and effector function and that they are required for
control of chronic cHV68 infection in the absence of classical
Class Ia molecules. The unconventional CD8 T cells are b2-m–
dependent, but CD1d-independent, and predominantly express Vb4, Vb3, and Vb10, as well as NK cell markers such as
NKG2A and NKG2D. They exhibit a diverse TCR repertoire,
consistent with a potential to respond to different viral
antigens. This is the ﬁrst demonstration of the development
PLoS Pathogens | www.plospathogens.org
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Figure 5. The Anti-cHV68 CD8 T Cell Response Encompasses Substantial CDR3 Length Diversity in Both Wild-Type and Kb/xDb/ Mice
TCR CDR3 length analysis of CD8 T cells obtained from the spleens of B6 and Kb/xDb/ mice 42 d after mock-infection or cHV68 infection. Shown on
the x-axis is CDR3 length within the CD8 T cell populations expressing Vb3, Vb4, Vb10, or Vb20. The y-axis represents the relative abundance of mRNA
encoding TCR chains of individual CDR3 lengths. Data are from one of two representative experiments. Arrows indicate an asymmetric peak to the right
of the center observed in the subdominant Vb10 response from both the wild-type and Kb/xDb/ mice.
DOI: 10.1371/journal.ppat.0020037.g005

such cells play a role when Class Ia molecules are present
must await identiﬁcation of speciﬁc mechanisms of activation
and selection for these cells and loss of function approaches
based on that information, or identiﬁcation of cell surface
molecules that are speciﬁc to this interesting set of CD8 T
cells, followed by depletion studies.
The observation that b2-m deﬁciency disrupts immunity to
chronic cHV68 infection was initially attributed to decreased
Class Ia expression on b2-m–deﬁcient cells [40]. This
interpretation is not correct because data presented here
demonstrate that effective control of long-term latency does
not require Class Ia molecules. Moreover, since b2-m
deﬁciency resulted in a more-severe loss of control of latency
than did Class Ia deﬁciency alone, we hypothesize that b2-m
has an important functional role in controlling infection in
addition to its more commonly known function as the
essential light chain for Class Ia proteins. Consistent with
this, Kb/xDb/xb2-m/ mice have much higher levels of
latency and persistent infection in both splenocytes and
peritoneal cells than Kb/xDb/ mice. The simplest explanation for this Class Ia–independent role for b2-m in control of
chronic viral infection is that b2-m–dependent, but Class Ia–
independent, unconventional CD8 T cells are important for
control of cHV68 infection. We speculate that these cells are
restricted by b2-m–dependent MHC Class Ib molecules.
T cells restricted to MHC Class Ib proteins are often monoor oligoclonal with regard to TCRa and/or TCRb usage. This
characteristic has been observed in HLA-E-restricted CD8 T
cells in humans [72], MR1-restricted mucosal-associated T
cells [73], and CD1d-restricted NKT cells [74]. Thus, the Vb4-,

of a diverse and functionally important Class Ia–independent
CD8 T cell response during chronic viral infection.
Several previously published studies have demonstrated
that CD8 T cells are important for control of cHV68
infection [19,20,25,43], and that Class Ia–restricted CD8 T
cells speciﬁc for both lytic and latent cHV68 antigens can
mediate protection [21,39]. Furthermore, vaccination with
immunodominant Class Ia–binding cHV68 peptides can
decrease acute titers and transiently decrease the early form
of latency [69–71], and adoptive transfer of latent virus
antigen-speciﬁc Class Ia–restricted CD8 T cells decreases
latency early after infection [28]. Thus, there is no question
that conventional Class Ia–restricted CD8 T cells are an
important part of the response to cHV68 infection. The data
presented here add unconventional CD8 T cells to the host’s
anti-viral armamentarium for control of chronic infection,
and indicate that the role of unconventional CD8 T cells
needs to be systematically explored in chronic viral infections. These T cells might be particularly important for
control of viruses that actively inhibit expression of host cell
MHC Class I as a mechanism of immune evasion.
Our experiments did not address the extent to which
unconventional CD8 T cells function as effector cells in wildtype mice. We speculate that these cells do play a role in
normal hosts based on the presence of T cells with similar
markers in normal hosts and the diverse TCR repertoire used
by these unconventional CD8 T cells. Moreover, CDR3
repertoire analysis suggests that some CDR3 lengths (and,
perhaps, T cell clones) may be shared between the responses
in wild-type and Kb/xDb/ mice. However, the proof that
PLoS Pathogens | www.plospathogens.org
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Figure 6. Unconventional CD8 T Cells Express Effector Molecules in Infected Class Ia–Deficient Mice
Splenocytes were harvested from B6 and Kb/xDb/ mice 42 d after mock infection or cHV68 infection, and analyzed by flow cytometry.
(A) Representative flow cytometric analysis of intracellular IFNc and TNFa expression by CD8 T cells from B6 and Kb/xDb/ mice that were either mock
infected or cHV68 infected for 42 d.
(B) Absolute number of total CD8 T cells and Vb4 CD8 T cells expressing intracellular IFNc and TNFa in mice that were mock infected or cHV68 infected
for 42 d. Data are the mean of two independent experiments using five to ten mice per group, 6 SEM.
(C) Representative flow cytometric analysis of intracellular IFNc, intracellular TNFa versus Vb4 expression by CD8 T cells from B6 and Kb/xDb/ mice
that were either mock-infected or cHV68-infected for 42 d. Representative from one of two experiments.
DOI: 10.1371/journal.ppat.0020037.g006

T cells that developed during chronic cHV68 infection
express high levels of NKG2A, which interacts with Qa1.
In summary, we demonstrate here that cHV68 infection
triggers a robust b2-m–dependent, Class Ia–independent, and
CD1d-independent unconventional CD8 T cell response that
can control cHV68 latency and persistent replication. These
ﬁndings make two important points regarding immunity to
chronic viral infection: (1) Class Ia–independent non-classical
CD8 T cells can control latent herpesvirus infection, and (2)
the role of b2-m in immunity to chronic viral infection is not
limited to its function as a light chain for Class Ia molecules.
It is possible that similar Class Ia–independent CD8 T cells
are required for control of other chronic viral infections,
such as human herpesviruses, HIV, hepatitis C virus, hepatitis
B virus, and lymphocytic choriomeningitis virus (LCMV).
Furthermore, since Class Ia proteins are not essential for
anti-viral CD8 T cell responses, CD8 T cell–directed
vaccination strategies that target only Class Ia–presented
antigens may not induce a maximal antiviral response.

Vb3-, and Vb10-biased nature of the CD8 T cell response to
cHV68 in Class Ia–deﬁcient mice is consistent with the
presence of one or more populations of MHC Class Ib–
restricted CD8 T cells. An important role for one or more
MHC Class Ib molecules in cHV68 immunity could therefore
explain both the importance of b2-m for efﬁcient expansion
of CD8 T cells in Class Ia–deﬁcient mice, and the Vb bias of
the unconventional CD8 T cells demonstrated herein.
We ruled out a contribution for CD1d in control of chronic
cHV68 infection, but other candidates remain. CD8 T cells
restricted to the Class Ib molecules Qa-1 and H2-M3
contribute to resistance to intracellular bacteria such as
Listeria monocytogenes and Mycobacterium tuberculosis [75–78]. In
humans, H2-M3 has been shown to present inﬂuenza virus
peptides to a human CD8 T cell clone [79]. In addition, a
population of CD8 T cells that recognizes peptides derived
from human beta- and c-herpesviruses in the context of
HLA-E, the human homolog of Qa-1, has been identiﬁed [72].
This latter observation is of particular interest since the CD8
PLoS Pathogens | www.plospathogens.org
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Materials and Methods

cells reactivating from latency was assayed as described [40]. Brieﬂy,
serial 2-fold dilutions of harvested cells (24 wells/dilution starting at 1
3 105 cells/well for splenocytes and 4 3 104 cells/well for peritoneal
cells) were plated onto permissive mouse embryonic ﬁbroblast
monolayers (MEFs) for 21 d, then scored for cytopathic effect that
are due to reactivating virus. To determine if samples contained
preformed infectious virus at harvest due to persistent replication,
replicate cell aliquots were mechanically disrupted prior to limiting
dilution and plating.
Limiting dilution PCR analysis. To determine the frequency
of cells carrying the cHV68 genome, single-copy sensitivity
nested PCR for the cHV68 v-cyclin (gene 72), was performed on serial
dilutions of cells as described [1,24]. Primers for v-cyclin were
59gagatctgtactcaggcacctgt39 and 59ggatttcttgacagctccctgt39 for round
1, and 59tgtcagctgttgttgctcct39 and 59ctccgtcaggataacaacgtct39 for
round 2. One false positive was detected in 246 reactions across all
experiments. Positive control reactions containing ten, one, or 0.1
copies of v-cyclin plasmid DNA were positive in 99%, 42%, and 5% of
all reactions, respectively.
Statistical analysis. All data points represent the mean 6 the
standard error of the mean (SEM) for two to three experiments with
three to ﬁve mice per condition per experiment. To quantify the
frequency of cells from which the virus reactivated or that carried
latent viral genome, data were subjected to nonlinear regression
using GraphPad Prism (GraphPad, San Diego, California, United
States). Frequencies were determined using the Poisson distribution
assuming that the cell number at which 63.2% of the wells scored
positive for reactivation or viral genome represented a single event.
To calculate signiﬁcance, data were statistically analyzed by unpaired
t test. For limiting dilution analyses, the calculated frequencies were
compared by unpaired t test.

Mice. C57BL/6J [B6, Jackson# 000664] mice and mice deﬁcient in
either the CD8a chain (CD8/, Jackson# 002665, [80]) or b2-m (b2-m/,
Jackson# 002087, [81,82]) were obtained from The Jackson Laboratories (Bar Harbor, Maine, United States). Kb/xDb/ mice [51] were
a generous gift from both Dr. Ted Hansen and Dr. Albert Bendelac.
Kb/xD b/x b2-m/ (Kb/xD b/ x b2-m/) mice were a generous gift of
Dr. Ted Hansen [52]. CD1d/ [83] and Kb/xDb/xCD1d/ (Kb/xDb/x
CD1d/) mice were a generous gift of Dr. Albert Bendelac. All mice
were on the B6 background and were bred and housed at Washington
University School of Medicine in accordance with all Federal and
University guidelines. Eight- to 12-wk-old mice were used for all
experiments.
Cell culture and virus infection. NIH 3T12 and B6 mouse
embryonic ﬁbroblasts were maintained as described [40]. cHV68
clone WUMS (ATCC VR1465) was passed and titered by plaque assay
on NIH 3T12 cells [40]. Mice were infected intraperitoneally with 106
PFU in 0.5 ml Dulbecco modiﬁed Eagle’s Medium with 1% fetal calf
serum (DMEM-1) [23]. Mock-infected animals were injected intraperitoneally with NIH 3T12 cell lysate diluted in DMEM-1.
Preparation of splenocytes, antibodies, and ﬂow cytometry. Singlecell suspensions of splenocytes were prepared for ﬂow cytometry as
described [40]. Splenocytes, 106 per condition, were incubated in
FACS-blocking buffer (13 PBS with 1.0% BSA, 0.1% sodium azide
plus rat anti-mouse CD16/CD32 [clone 2.4G2, ATCC#HB-197] and
5% rat serum) for 30 min on ice. Five percent mouse serum was
added for NKG2A/C/E staining. Antibody staining for cell surface
markers was performed in 100 ll of FACS buffer (13 PBS with 1.0%
BSA, 0.1% sodium azide) on ice for 45 min, followed by three washes
of (200 ll each) of FACS buffer. The cells were then ﬁxed in 1%
paraformaldehyde (in PBS) and stored in FACS buffer until analyzed.
For intracellular staining, cells were activated with 20-ng/ml PMA
plus1 lM ionomycin for 4–6 h in the presence of GolgiPlug from the
Cytoﬁx/Cytoperm kit from BD Pharmingen (San Diego, California,
United States). After staining the cells for surface markers, cells were
ﬁxed and permeabilized using the Cytoﬁx/Cytoperm kit according to
the manufacturer’s instructions. Next, the cells were stained with
antibodies speciﬁc to IFNc and TNFa, and then washed and
resuspended in FACS buffer prior to analysis. PE anti-CD43,
CD62L, CD122, CD127, CD44, CD69, DX5, CD4, abTCR, TNFa, PElabeled strepavidin, CyChrome anti-CD3, ﬂuorescein isothiocyanate
(FITC) anti-CD4, PE, allophycocyanin (APC) and Alexa 488 antiIFNc, biotin anti-NKG2A/C/E, and FITC anti-TCRb (pan b, clone
H57–597) were obtained from BD Pharmingen. TCR V Beta usage of
T cells from mock-infected and infected Kb/xDb/ mice was
performed using the mouse Vb TCR Screening Panel (BD Pharmingen, Catalog# 557004) according to the manufacturer’s instructions.
Labeled isotype–matched control antibodies were obtained from BD
Pharmingen. Stained cell populations were processed with a
FACSCaliber ﬂow cytometer (BD Pharmingen), and the data were
analyzed with either CellQuest (BD Pharmingen) or FCS Express
Version 2 software (De Novo Software, Ontario, Canada).
CDR3 length analysis. The PCR conditions and the primers were
described previously [84]. CDR3 length polymorphism proﬁles of Vb
families were obtained using the Immunoscope software, depicting
the relative intensity of bands migrating to the same CDR3 nucleotide
length, as previously described [84].
Plaque assays. Plaque assays were performed as previously
described [40]. Brieﬂy, organs were harvested into sterile, screw-top
2-ml tubes containing 1 ml of DMEM and 100 ll of 1-mm zirconia/
silica beads (BioSpec Products, Bartlesville, Oklahoma, United States)
and stored at 80 8C. Samples were thawed on ice and homogenized
using a Mini BeadBeater (BioSpec Products), then further diluted in
DMEM prior to infecting NIH 3T12 monolayers. Infected monolayers
were overlaid with Noble agar, and plaques were visualized at 7 d
post-harvest using neutral red staining. The limit of detection was 50
PFU.
In vivo depletion of lymphocyte subsets. Monoclonal antibodies
were produced in INTEGRA Celline CL1000 ﬂasks (Integra Biosciences, Ijamsville, Maryland, United States) as described [20].
Beginning 1 d prior to virus infection, 2 mg of CD8-depleting
antibody (H35, [85]) or an isotype-matched control antibody (SFR3DR5, IgG2b, ATCC HB-151, [86]) were administered to each mouse by
intraperitoneal injection. Monoclonal antibodies (1 mg) were
administered every fourth day thereafter. The efﬁcacy of CD8
depletion was monitored by ﬂow cytometric analysis of splenocytes
and was 94% or greater in each case.
Ex vivo limiting dilution reactivation analysis. The frequency of
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Supporting Information
Figure S1. Control of Chronic cHV68 Infection Is Dependent on CD8
T Cells
(A) Frequency of cells reactivating from latency ex vivo (left),
frequency of cells bearing viral genome (middle), and persistent
replication (right) at day 42 post-infection in peritoneal cells from
B6, Kb/xD b/, and CD8/ mice. On the y-axis is the percentage of
wells positive for viral cytopathic effect (left and right) or viral
genome (middle). The horizontal line within the graph indicates the
63.2% Poisson distribution line used to calculate the frequency of
cells reactivating virus. Data are the mean of three to four
independent experiments 6 SEM.
(B) Frequency of latent infection in splenocytes from B6, Kb/xDb/,
and CD8/ mice. Data are the mean of three to four independent
experiments 6 SEM.
Found at DOI: 10.1371/journal.ppat.0020037.sg001 (219 KB TIF).
Figure S2. Efﬁcacy of CD8 T Cell Depletion as Assessed by Flow
Cytometry
Splenocytes from Kb/xDb/xCD1d/ mice that were either treated
with a CD8-depleting antibody (Ab) or an irrelevant control antibody
were harvested 16 d after cHV68 infection and analyzed by ﬂow
cytometry. Panels show representative ﬂow cytometric analysis of
CD4 and CD8 expression on splenocytes.
Found at DOI: 10.1371/journal.ppat.0020037.sg002 (398 KB TIF).

Acknowledgments
We would like to thank Albert Bendelac and Ted Hansen for
providing mice. We thank Ted Hansen for many helpful discussions.
Author contributions. All the authors conceived and designed the
experiments. DCB, JSM, IM, and KBM performed the experiments.
All the authors analyzed the data. JNZ and HWV contributed
reagents/materials/analysis tools. DCB, JSM, and HWV wrote the
paper.
Funding. This work was supported by National Institutes of Health
grants RO1 CA74730 and RO1 CA96511 to HWV. JNZ and IM were
supported by RO1 AI066096. DCB was a Leukemia and Lymphoma
Society Fellow. JSM was supported by a pre-doctoral fellowship from
the Cancer Research Institute. SAT is a Leukemia and Lymphoma
Society Special Fellow (#3460–04).
Competing interests. The authors have declared that no competing
&
interests exist.

0405

May 2006 | Volume 2 | Issue 5 | e37

Virus Control by Unconventional CD8 T Cells
References
1. Weck KE, Kim SS, Virgin HW, Speck SH (1999) Macrophages are the major
reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol
73: 3273–3283.
2. Flano E, Kim IJ, Woodland DL, Blackman MA (2002) gamma-Herpesvirus
latency is preferentially maintained in splenic germinal center and memory
B cells. J Exp Med 196: 1363–1372.
3. Willer DO, Speck SH (2003) Long-term latent murine Gammaherpesvirus
68 infection is preferentially found within the surface immunoglobulin Dnegative subset of splenic B cells in vivo. J Virol 77: 8310–8321.
4. Flano E, Husain SM, Sample JT, Woodland DL, Blackman MA (2000) Latent
murine gamma-herpesvirus infection is established in activated B cells,
dendritic cells, and macrophages. J Immunol 165: 1074–1081.
5. Sunil-Chandra NP, Efstathiou S, Nash AA (1992) Murine gammaherpesvirus
68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol
73: 3275–3279.
6. Roizman B, Pellett PE (2001) The family Herpesviridae: A brief introduction. In: Knipe DM, Howley PM, editors. Fields virology. 4th edition.
Philadelphia: Lippincott Williams & Wilkins. pp. 2381–2397.
7. Sunil-Chandra NP, Arno J, Fazakerley J, Nash AA (1994) Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am J
Pathol 145: 818–826.
8. Cesarman E, Knowles DM (1999) The role of Kaposi’s sarcoma-associated
herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Semin Cancer
Biol 9: 165–174.
9. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi’s
sarcoma-associated herpesvirus-like DNA sequences in AIDS-related bodycavity-based lymphomas. N Engl J Med 332: 1186–1191.
10. Rickinson AB, Kieff E (2001) Epstein-Barr virus. In: Knipe DM, Howley P,
editors. Fields virology. 4th edition. Philadelphia: Lippincott Williams &
Wilkins. pp. 2575–2627.
11. Moore PS, Chang Y (2001) Kaposi’s sarcoma-associated herpesvirus. In:
Knipe DM, Howley P, editors. Fields virology. 4th edition. Philadelphia:
Lippincott Williams & Wilkins. pp. 2803–2833.
12. Tarakanova VL, Suarez FS, Tibbetts SA, Jacoby M, Weck KE, et al. (2005)
Murine gammaherpesvirus 68 infection induces lymphoproliferative
disease and lymphoma in BALB c2 microglobulin deﬁcient mice. J Virol
79: 14668–14679.
13. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994)
Identiﬁcation of herpesvirus-like DNA sequences in AIDS-associated
Kaposi’s sarcoma. Science 266: 1865–1869.
14. Savoie A, Perpete C, Carpentier L, Joncas J, Alﬁeri C (1994) Direct
correlation between the load of Epstein-Barr virus-infected lymphocytes in
the peripheral blood of pediatric transplant patients and risk of
lymphoproliferative disease. Blood 83: 2715–2722.
15. Weck KE, Dal Canto AJ, Gould JD, O’Guin AK, Roth KA, et al. (1997)
Murine gammaherpesvirus 68 causes severe large vessel arteritis in mice
lacking interferon-gamma responsiveness: a new model for virus induced
vascular disease. Nat Med 3: 1346–1353.
16. Dal Canto AJ, Swanson PE, O’Guin AK, Speck SH, Virgin HW (2001) IFNgamma action in the media of the great elastic arteries, a novel
immunoprivileged site. J Clin Invest 107: R15–R22.
17. Sparks-Thissen RL, Braaten DC, Kreher S, Speck SH, Virgin HW (2004) An
optimized CD4 T-cell response can control productive and latent
gammaherpesvirus infection. J Virol 78: 6827–6835.
18. Sparks-Thissen RL, Braaten DC, Hildner K, Murphy TL, Murphy KM, et al.
(2005) CD4 T cell control of acute and latent murine gammaherpesvirus
infection requires IFNgamma. Virology 338: 201–208.
19. Braaten DC, Sparks-Thissen RL, Kreher S, Speck SH, Virgin HW (2005) An
optimized CD8þ T-cell response controls productive and latent gammaherpesvirus infection. J Virol 79: 2573–2583.
20. McClellan JS, Tibbetts SA, Gangappa S, Brett KA, Virgin HW (2004) Critical
role of CD4 T cells in an antibody-independent mechanism of vaccination
against gamma-herpesvirus latency. J Virol 78: 6836–6845.
21. Stevenson PG, Belz GT, Altman JD, Doherty PC (1999) Changing patterns of
dominance in the CD8þ T cell response during acute and persistent murine
gamma-herpesvirus infection. Eur J Immunol 29: 1059–1067.
22. Stevenson PG, Doherty PC (1998) Kinetic analysis of the speciﬁc host
response to a murine gammaherpesvirus. J Virol 72: 943–949.
23. Tibbetts SA, Loh J, van Berkel V, McClellan JS, Jacoby MA, et al. (2003)
Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J Virol 77: 7696–7701.
24. Tibbetts SA, McClellan JS, Gangappa S, Speck SH, Virgin HW (2003)
Effective vaccination against long-term gammaherpesvirus latency. J Virol
77: 2522–2529.
25. Tibbetts SA, Van Dyk L, Speck SH, Virgin HW (2002) Immune control of
the number and reactivation phenotype of cells latently infected with a
gamma-herpesvirus. J Virol 76: 7125–7132.
26. Tripp RA, Hamilton-Easton AM, Cardin RD, Nguyen P, Behm FG, et al.
(1997) Pathogenesis of an infectious mononucleosis-like disease induced by
a murine gamma-herpesvirus: Role for a viral superantigen? J Exp Med 185:
1641–1650.
27. Kim IJ, Flano E, Woodland DL, Blackman MA (2002) Antibody-mediated
control of persistent gamma-herpesvirus infection. J Immunol 168: 3958–3964.

PLoS Pathogens | www.plospathogens.org

28. Usherwood EJ, Roy DJ, Ward K, Surman SL, Dutia BM, et al. (2000) Control
of gammaherpesvirus latency by latent antigen-speciﬁc CD8(þ) T cells. J
Exp Med 192: 943–952.
29. Flano E, Kim IJ, Moore J, Woodland DL, Blackman MA (2003) Differential
gamma-herpesvirus distribution in distinct anatomical locations and cell
subsets during persistent infection in mice. J Immunol 170: 3828–3834.
30. Weck KE, Kim SS, Virgin HW, Speck SH (1999) B cells regulate murine
gammaherpesvirus 68 latency. J Virol 73: 4651–4661.
31. Gangappa S, Van Dyk LF, Jewett TJ, Speck SH, Virgin HW (2002)
Identiﬁcation of the in vivo role of a viral bcl-2. J Exp Med 195: 931–940.
32. Steed A, Barton ES, Tibbetts SA, Popkin DL, Lutzke ML, et al. (2006)
Gamma interferon blocks gammaherpesvirus reactivation from latency. J
Virol 80: 192–200.
33. Barton ES, Lutzke ML, Rochford R, Virgin HW (2005) Alpha/beta
interferons regulate murine gammaherpesvirus latent gene expression
and reactivation from latency. J Virol 79: 14149–14160.
34. Gangappa S, Kapadia SB, Speck SH, Virgin HW (2002) Antibody to a lytic
cycle viral protein decreases gammaherpesvirus latency in B-cell-deﬁcient
mice. J Virol 76: 11460–11468.
35. Van Dyk LF, Virgin HW, Speck SH (2000) The murine gammaherpesvirus
68 v-cyclin is a critical regulator of reactivation from latency. J Virol 74:
7451–7461.
36. Van Dyk LF, Virgin HW, Speck SH (2003) Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes. J Virol
77: 5118–5126.
37. Belz GT, Doherty PC (2001) Virus-speciﬁc and bystander CD8þ T-cell
proliferation in the acute and persistent phases of a gammaherpesvirus
infection. J Virol 75: 4435–4438.
38. Hamilton-Easton AM, Christensen JP, Doherty PC (1999) Turnover of T
cells in murine gammaherpesvirus 68-infected mice. J Virol 73: 7866–7869.
39. Husain SM, Usherwood EJ, Dyson H, Coleclough C, Coppola MA, et al.
(1999) Murine gammaherpesvirus M2 gene is latency-associated and its
protein a target for CD8(þ) T lymphocytes. Proc Natl Acad Sci U S A 96:
7508–7513.
40. Weck KE, Barkon ML, Yoo LI, Speck SH, Virgin HW (1996) Mature B cells
are required for acute splenic infection, but not for establishment of
latency, by murine gammaherpesvirus 68. J Virol 70: 6775–6780.
41. Ehtisham S, Sunil-Chandra NP, Nash AA (1993) Pathogenesis of murine
gammaherpesvirus infection in mice deﬁcient in CD4 and CD8 T cells. J
Virol 67: 5247–5252.
42. Coppola MA, Flano E, Nguyen P, Hardy CL, Cardin RD, et al. (1999)
Apparent MHC-independent stimulation of CD8þ T cells in vivo during
latent murine gammaherpesvirus infection. J Immunol 163: 1481–1489.
43. Stevenson PG, Cardin RD, Christensen JP, Doherty PC (1999) Immunological control of a murine gammaherpesvirus independent of CD8þ T
cells. J Gen Virol 80: 477–483.
44. Flano E, Hardy CL, Kim IJ, Frankling C, Coppola MA, et al. (2004) T cell
reactivity during infectious mononucleosis and persistent gammaherpesvirus infection in mice. J Immunol 172: 3078–3085.
45. Braud VM, Allan DS, McMichael AJ (1999) Functions of nonclassical MHC
and non-MHC-encoded class I molecules. Curr Opin Immunol 11: 100–108.
46. Wilson IA, Bjorkman PJ (1998) Unusual MHC-like molecules: CD1, Fc
receptor, the hemochromatosis gene product, and viral homologs. Curr
Opin Immunol 10: 67–73.
47. Cook JR, Solheim JC, Connoly JM, Hansen TH (1995) Induction of peptidespeciﬁc CD8þ CTL clones in beta 2-microglobulin-deﬁcient mice. J
Immunol 154: 47–57.
48. Ljunggren HG, Glas R, Sandberg JK, Karre K (1996) Reactivity and
speciﬁcity of CD8(þ) T cells in mice with defects in the MHC class I antigenpresenting pathway. Immunol Rev 151: 123–148.
49. Lehmann-Grube F, Dralle H, Utermohlen O, Lohler J (1994) MHC class I
molecule-restricted presentation of viral antigen in beta 2-microglobulindeﬁcient mice. J Immunol 153: 595–603.
50. D’Orazio SEF, Halme DG, Ploegh HL, Starnbach MN (2003) Class Ia MHCdeﬁcient BALB/c mice generate CD8(þ) T cell-mediated protective
immunity against Listeria monocytogenes infection. J Immunol 171: 291–
298.
51. Vugmeyster Y, Glas R, Perarnau B, Lemonnier FA, Eisen H, et al. (1998)
Major histocompatibility complex (MHC) class I KbDb -/- deﬁcient mice
possess functional CD8þ T cells and natural killer cells. Proc Natl Acad Sci
U S A 95: 12492–12497.
52. Lybarger L, Wang X, Harris MR, Virgin HW, Hansen TH (2003) Virus
subversion of the MHC class I peptide-loading complex. Immunity 18: 121–
130.
53. Sanchez DJ, Gumperz JE, Ganem D (2005) Regulation of CD1d expression
and function by a herpesvirus infection. J Clin Invest 115: 1369–1378.
54. Hegde NR, Johnson DC (2005) A seek-and-hide game between Cd1restricted T cells and herpesviruses. J Clin Invest 115: 1146–1149.
55. Shortman K, Liu YJ (2002) Mouse and human dendritic cell subtypes.
Nature Reviews Immunology 2: 151–161.
56. Vremec D, Zorbas M, Scollay R, Saunders DJ, Ardavin CF, et al. (1992) The
surface phenotype of dendritic cells puriﬁed from mouse thymus and
spleen: Investigation of the Cd8 expression by a subpopulation of dendritic
cells. J Exp Med 176: 47–58.
57. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K (2000) CD4 and CD8

0406

May 2006 | Volume 2 | Issue 5 | e37

Virus Control by Unconventional CD8 T Cells

58.

59.

60.

61.
62.
63.
64.

65.

66.

67.

68.
69.

70.

71.

72. Moretta L, Romagnani C, Pietra G, Moretta A, Mingari MC (2003) NKCTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol 24: 136–143.
73. Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, et al. (2003)
Selection of evolutionarily conserved mucosal-associated invariant T cells
by MR1. Nature 422: 164–169.
74. Bendelac A, Rivera MN, Park SH, Roark JH (1997) Mouse CD1-speciﬁc NK1
T cells: Development, speciﬁcity, and function. Annu Rev Immunol 15:
535–562.
75. Pamer EG, Wang CR, Flaherty L, Lindahl KF, Bevan MJ (1992) H-2M3
presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Cell
70: 215–223.
76. Soloski MJ, Szperka ME, Davies A, Wooden SL (2000) Host immune
response to intracellular bacteria: A role for MHC-linked class-Ib antigenpresenting molecules. Proc Soc Exp Biol Med 224: 231–239.
77. Chun T, Serbina NV, Nolt D, Wang B, Chiu NM, et al. (2001) Induction of
M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides
derived from Mycobacterium tuberculosis. J Exp Med 193: 1213–1220.
78. Lo WF, Ong H, Metcalf ES, Soloski MJ (1999) T cell responses to gramnegative intracellular bacterial pathogens: A role for CD8(þ) T cells in
immunity to Salmonella infection and the involvement of MHC class Ib
molecules. J Immunol 162: 5398–5406.
79. Byers DE, Lindahl KF (1998) H2-M3 presents a nonformylated viral epitope
to CTLs generated in vitro. J Immunol 161: 90–96.
80. Fung-Leung WP, Schilham MW, Rahemtulla A, Kundig TM, Vollenweider
M, et al. (1991) CD8 is needed for development of cytotoxic T cells but not
helper T cells. Cell 65: 443–449.
81. Koller BH, Marrack P, Kappler JW, Smithies O (1990) Normal development
of mice deﬁcient in beta 2M, MHC class I proteins, and CD8þ T cells.
Science 248: 1227–1230.
82. Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, et al. (1990) Beta 2microglobulin deﬁcient mice lack CD4–8þ cytolytic T cells. Nature 344:
742–746.
83. Chen YH, Chiu NM, Mandal M, Wang N, Wang CR (1997) Impaired NK1(þ)
T cell development and early IL-4 production in CD1-deﬁcient mice.
Immunity 6: 459–467.
84. LeMaoult J, Messaoudi I, Manavalan JS, Potvin H, Nikolich-Zugich D, et al.
(2000) Age-related dysregulation in CD8 T cell homeostasis: Kinetics of a
diversity loss. J Immunol 165: 2367–2373.
85. Smith SC, Allen PM (1991) Myosin-induced acute myocarditis is a T cellmediated disease. J Immunol 147: 2141–2147.
86. Radka SF, Machamer C, Cresswell P, Kostyu DD, Ward FE, et al. (1983)
SFR3-DR5, a monoclonal antibody with HLA-DR5 speciﬁcity. J Immunol
130: 1863–1866.

expression by dendritic cell subtypes in mouse thymus and spleen. J
Immunol 164: 2978–2986.
Das G, Janeway CA Jr. (1999) Development of CD8alpha/alpha and
CD8alpha/beta T cells in major histocompatibility complex class I-deﬁcient
mice. J Exp Med 190: 881–884.
Kessler B, Hudrisier D, Schroeter M, Tschopp J, Cerottini JC, et al. (1998)
Peptide modiﬁcation or blocking of CD8, resulting in weak TCR signaling,
can activate CTL for Fas- but not perforin-dependent cytotoxicity or
cytokine production. J Immunol 161: 6939–6946.
Naeher D, Luescher IF, Palmer E (2002) A role for the alpha-chain
connecting peptide motif in mediating TCR-CD8 cooperation. J Immunol
169: 2964–2970.
Gourley TS, Wherry EJ, Masopust D, Ahmed R (2004) Generation and
maintenance of immunological memory. Semin Immunol 16: 323–333.
Wherry EJ, Ahmed R (2004) Memory CD8 T-cell differentiation during viral
infection. J Virol 78: 5535–5545.
Seder RA, Ahmed R (2003) Similarities and differences in CD4(þ) and
CD8(þ) effector and memory T cell generation. Nat Immunol 4: 835–842.
Laouini D, Casrouge A, Dalle S, Lemonnier F, Kourilsky P, et al. (2000) V
beta T cell repertoire of CD8(þ) splenocytes selected on nonpolymorphic
MHC class I molecules. J Immunol 165: 6381–6386.
Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, et al. (1993) The
sizes of the Cdr3 hypervariable regions of the murine T-cell receptor betachains vary as a function of the recombined germ-line segments. Proc Natl
Acad Sci U S A 90: 4319–4323.
Pannetier C, Even J, Kourilsky P (1995) T-cell repertoire diversity and
clonal expansions in normal and clinical-samples. Immunol Today 16: 176–
181.
Even J, Lim A, Puisieux I, Ferradini L, Dietrich PY, et al. (1995) T-cell
repertoires in healthy and diseased human tissues analyzed by T-cell
receptor beta-chain Cdr3 size determination: Evidence for oligoclonal
expansions in rumors and inﬂammatory diseases. Res Immunol 146: 65–80.
Urdahl KB, Sun JC, Bevan MJ (2002) Positive selection of MHC class Ibrestricted CD8(þ) T cells on hematopoietic cells. Nat Immunol 3: 772–779.
Belz GT, Stevenson PG, Castrucci MR, Altman JD, Doherty PC (2000)
Postexposure vaccination massively increases the prevalence of gammaherpesvirus-speciﬁc CD8þ T cells but confers minimal survival advantage
on CD4-deﬁcient mice. Proc Natl Acad Sci U S A 97: 2725–2730.
Woodland DL, Usherwood EJ, Liu L, Flano E, Kim IJ, et al. (2001)
Vaccination against murine gamma-herpesvirus infection. Viral Immunol
14: 217–226.
Liu L, Usherwood EJ, Blackman MA, Woodland DL (1999) T-cell
vaccination alters the course of murine herpesvirus 68 infection and the
establishment of viral latency in mice. J Virol 73: 9849–9857.

PLoS Pathogens | www.plospathogens.org

0407

May 2006 | Volume 2 | Issue 5 | e37

